White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Regulation of the immune checkpoint PD-L1 by microRNAs

Yee, Daniel (2018) Regulation of the immune checkpoint PD-L1 by microRNAs. PhD thesis, University of York.

This is the latest version of this item.

[img]
Preview
Text
Thesis - DY - Final.pdf - Examined Thesis (PDF)
Available under License Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 UK: England & Wales.

Download (11Mb) | Preview

Abstract

MicroRNAs are evolutionary conserved non-coding RNAs that control more than 60% of human protein-coding genes at the posttranscriptional level. MicroRNAs can either mediate translational repression or mRNA degradation by complementary base-pairing to the 3’-UTR of mRNA. MicroRNAs have critical roles in the regulation of immune responses and inflammation. The expression of PD-L1 protein is found on some normal and cancer cells and contributes to suppression of T cell activity by acting as a brake on the immune response. Previously, it has been shown that posttranscriptional mechanisms regulate PD-L1 levels in cancer, it remains unknown whether such regulatory networks operate also in non-transformed cells. Here, I tested the hypothesis that expression and function of PD-L1 in stromal, vascular and cancer cells is posttranscriptionally regulated by inflammatory-driven microRNAs. I demonstrate that PD-L1 expression in human dermal lymphatic endothelial cells (HDLECs) can be induced with the treatment of pro-inflammatory cytokines IFN-y and TNF-a. The microRNA landscape in HDLECs was activated by IFN-y and TNF-a treatment including some microRNAs that have predicted binding sites on PD-L1. A highly upregulated microRNA was microRNA-155 (miR-155), a multifunctional microRNA that regulates haematopoiesis, normal immune function and mediates the inflammatory response. I determined that miR-155 can bind to the 3’-UTR of PD-L1 on two functional binding sites, and that the kinetics of PD-L1 induction is fine-tuned by inflammation-induced miR-155 in HDLECs and dermal fibroblasts. Interestingly, I found that miR-155 can also silence PD-L1 expression in renal, breast but only in a subset of lung cancer cell lines. These findings reveal that inflammatory activation induce PD-L1 expression on several different cell types presumably to avoid prolonged immune-mediated tissue damage. However, miR-155 can act in a cell type-specific manner to temporally release PD-L1 immunosuppression to regulate the balance between immune tolerance and autoimmunity.

Item Type: Thesis (PhD)
Related URLs:
Academic Units: The University of York > Biology (York)
Depositing User: Dr Daniel Yee
Date Deposited: 04 Jun 2019 13:52
Last Modified: 04 Jun 2019 13:52
URI: http://etheses.whiterose.ac.uk/id/eprint/23914

Available Versions of this Item

  • Regulation of the immune checkpoint PD-L1 by microRNAs. (deposited 04 Jun 2019 13:52) [Currently Displayed]

You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.

Actions (repository staff only: login required)